Woodline Partners LP Arrowhead Pharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $10.5 Billion
- Q1 2024
A detailed history of Woodline Partners LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 555,628 shares of ARWR stock, worth $14 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
555,628
Previous 927,187
40.07%
Holding current value
$14 Million
Previous $28.4 Million
43.99%
% of portfolio
0.15%
Previous 0.32%
Shares
7 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$387 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$313 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$216 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$165 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$104 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.67B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...